We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+2.14%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$36.9B
AUM Growth
-$216M
(-0.58%)
Cap. Flow
-$321M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
8.45%
Holding
2,522
New
303
Increased
944
Reduced
1,005
Closed
237
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$240M |
| 3 |
Chevron
CVX
|
+$231M |
| 4 |
Amazon
AMZN
|
+$183M |
| 5 |
Citigroup
C
|
+$175M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$277M |
| 2 |
Lowe's Companies
LOW
|
+$253M |
| 3 |
Home Depot
HD
|
+$246M |
| 4 |
Danaher
DHR
|
+$174M |
| 5 |
Cisco
CSCO
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.03% |
| 2 | Technology | 15.23% |
| 3 | Healthcare | 11.73% |
| 4 | Industrials | 11.36% |
| 5 | Consumer Staples | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Seres Therapeutics
MCRB
$48M
| $128K | ﹤0.01% |
875
-900
| -51% | -$173K |
|
|
XRM
2202
DELISTED
Xerium Technologies Inc (new)
XRM
| $128K | ﹤0.01% |
19,900
-600
| -3% | -$3.18K |
|
2203
Allot
ALLT
$374M
| $126K | ﹤0.01% |
23,009
-1,200
| -5% | -$6.39K |
|
2204
Goldgroup Mining Inc.
GORO
$151M
| $126K | ﹤0.01% |
28,000
+8,500
| +44% | +$38.3K |
|
2205
Lexicon Pharmaceuticals
LXRX
$1.02B
| $126K | ﹤0.01% |
14,648
+4,072
| +39% | +$37.7K |
|
|
MITL
2206
DELISTED
Mitel Networks Corporation
MITL
| $125K | ﹤0.01% |
13,466
+1,427
| +12% | +$12.5K |
|
2207
Citizens
CIA
$245M
| $123K | ﹤0.01% |
16,787
| – | – |
|
|
CLSD
2208
DELISTED
Clearside Biomedical
CLSD
| $122K | ﹤0.01% |
+760
| New | +$92.6K |
|
2209
Harvard Bioscience
HBIO
$27.1M
| $121K | ﹤0.01% |
2,416
-20
| -0.8% | -$897 |
|
2210
PhenixFIN
PFX
| $121K | ﹤0.01% |
1,524
+10
| +0.7% | +$916 |
|
|
SCWX
2211
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $121K | ﹤0.01% |
14,948
+4,100
| +38% | +$38.8K |
|
|
RSYS
2212
DELISTED
Radisys Corp
RSYS
| $120K | ﹤0.01% |
187,800
+1,800
| +1% | +$1.61K |
|
|
PCOM
2213
DELISTED
Points.com Inc. Common Shares
PCOM
| $119K | ﹤0.01% |
+12,200
| New | +$132K |
|
2214
Amtech Systems
ASYS
$278M
| $114K | ﹤0.01% |
15,600
-12,600
| -45% | -$113K |
|
2215
ICL Group
ICL
$6.81B
| $114K | ﹤0.01% |
26,800
-1,800
| -6% | -$7.7K |
|
2216
IDT Corp
IDT
$1.6B
| $113K | ﹤0.01% |
18,026
-47,960
| -73% | -$438K |
|
|
VRN
2217
DELISTED
Veren
VRN
| $112K | ﹤0.01% |
+16,500
| New | +$125K |
|
|
HIL
2218
DELISTED
Hill International, Inc. Common Stock
HIL
| $112K | ﹤0.01% |
19,600
+4,300
| +28% | +$24.3K |
|
|
AFH
2219
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
| $110K | ﹤0.01% |
+10,600
| New | +$179K |
|
|
TEF
2220
DELISTED
Telefonica
TEF
| $109K | ﹤0.01% |
+13,614
| New | +$108K |
|
|
GFA
2221
DELISTED
Gafisa S.A.
GFA
| $109K | ﹤0.01% |
17,400
+1,800
| +12% | +$16.8K |
|
2222
Smith & Wesson
SWBI
$655M
| $108K | ﹤0.01% |
13,663
-5,594
| -29% | -$47.1K |
|
|
AGEN
2223
Agenus
AGEN
$249M
| $106K | ﹤0.01% |
1,146
+453
| +65% | +$40.2K |
|
|
MVC
2224
DELISTED
MVC Capital, Inc.
MVC
| $104K | ﹤0.01% |
10,452
-3,600
| -26% | -$37.3K |
|
2225
Data I/O
DAIO
$32M
| $101K | ﹤0.01% |
13,600
+2,400
| +21% | +$23.9K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q1 2018 Portfolio in Review
As of Q1 2018, Two Sigma Advisers held 2,522 positions worth $36.9B, down 0.58% from $37.1B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Two Sigma Advisers's Q1 2018 filing shows 303 new, 944 increased, 1,005 reduced and 237 closed positions. Its largest new stake was Procter & Gamble: 3,490,366 shares worth $277M. The largest sale was Amgen, an estimated $277M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- Two Sigma Advisers's largest Q1 2018 buy was Procter & Gamble: 3,490,366 shares worth $277M.
- Two Sigma Advisers added most to PepsiCo in Q1 2018, an estimated $240M increase.
- Two Sigma Advisers's biggest Q1 2018 reduction was Amgen, cutting an estimated $277M.
- Two Sigma Advisers fully exited Constellation Brands in Q1 2018, selling an estimated $115M.
- Two Sigma Advisers's ten largest holdings make up 8.4% of its $36.9B portfolio in Q1 2018.
- Two Sigma Advisers opened 303 new positions and closed 237 in Q1 2018.
- Two Sigma Advisers's portfolio value fell 0.58% quarter-over-quarter to $36.9B.
Based on Two Sigma Advisers's 13F filing for Q1 2018, filed 15 May 2018.